0431, MK,
4-oxo-4-(3-(trifluoromethyl)-5,6-dihydro(1,2,4)triazolo(4,3-a)pyrazin-7(8H)-yl)-1-(2,4,5-trifluorophenyl)butan-2-amine,
Anhydrous, Sitagliptin Phosphate,
Januvia,
MK 0431,
MK-0431,
MK0431,
Monohydrate, Sitagliptin Monophosphate,
Monohydrate, Sitagliptin Phosphate,
Monophosphate Monohydrate, Sitagliptin,
Phosphate Anhydrous, Sitagliptin,
Phosphate Monohydrate, Sitagliptin,
Phosphate, Sitagliptin,
sitagliptin,
sitagliptin monophosphate monohydrate,
sitagliptin phosphate,
sitagliptin phosphate anhydrous,
sitagliptin phosphate monohydrate,
Sitagliptin phosphate,
654671-78-0,
Januvia,
Sitagliptin (phosphate),
MK-0431,
MK 0431,
UNII-494P4635I6,
CHEMBL393336,
MK0431,
494P4635I6,
(2R)-4-Oxo-4-(3-(trifluoromethyl)-5,6-dihydro(1,2,4)triazolo(4,3-a)pyrazin-7(8H)-yl)-1-(2,4,5-trifluorophenyl)butan-2-amine phosphate salt,
(3R)-3-amino-1-[3-(trifluoromethyl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]-4-(2,4,5-trifluorophenyl)-1-butanone; phosphoric acid,
(3R)-3-amino-1-[3-(trifluoromethyl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]-4-(2,4,5-trifluorophenyl)butan-1-one; phosphoric acid,
(R)-3-AMINO-1-(3-(TRIFLUOROMETHYL)-5,6-DIHYDRO-[1,2,4]TRIAZOLO[4,3-A]PYRAZIN-7(8H)-YL)-4-(2,4,5-TRIFLUOROPHENYL)BUTAN-1-ONE PHOSPHATE,
4-oxo-4-(3-(trifluoromethyl)-5,6-dihydro(1,2,4)triazolo(4,3-a)pyrazin-7(8H)-yl)-1-(2,4,5-trifluorophenyl)butan-2-amine phosphate,
4-Oxo-4-(3-(trifluoromethyl)-5,6-dihydro(1,2,4)triazolo[4,3-a]pyrazin-7(8H)-yl)-1-(2,4,5-trifluorophenyl)butan-2-amine phosphate,
SR-05000001748,
(2r)-4-oxo-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8h)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine phosphate salt,
AK198682,
MK 431,
AC1Q7DLF,
SCHEMBL877069,
AC1O52U4,
C16H18F6N5O5P,
CTK8F1330,
KS-00000OSI,
DTXSID10215789,
IQFYVLUXQXSJJN-SBSPUUFOSA-N,
HY-13749A,
MFCD09952339,
AKOS015896098,
AB55315,
API0000836,
CS-2915,
KS-1214,
RL04492,
AN-10494,
S053,
AB0007165,
AB1008523,
LS-186669,
RT-015712,
FT-0650741,
671S780,
A835125,
I06-1709,
SR-05000001748-2,
(3R)-3-amino-1-[3-(trifluoromethyl)-6,8-dihydro-5H-[1,2,4]triazolo[3,4-c]pyrazin-7-yl]-4-(2,4,5-trifluorophenyl)butan-1-one; phosphoric acid,
(3R)-3-azanyl-1-[3-(trifluoromethyl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]-4-[2,4,5-tris(fluoranyl)phenyl]butan-1-one; phosphoric acid,
1-Butanone, 3-amino-1-[5,6-dihydro-3-(trifluoromethyl)-1,2,4-triazolo[4,3-a]pyrazin-7(8H)-yl]-4-(2,4,5-trifluorophenyl)-, (3R)-, phosphate (1:1),
7-(3R)-3-Amino-1-oxo-4-(2,4,5-trifluorophenyl)butyl-5,6,7,8-tetrahydro-3-(trifluoromethyl)-1,2,4-triazolo[4,3-a]pyrazine phosphate,
847445-79-8,
Sitagliptin,
Sitagliptan,
sitagliptin phosphate anhydrous,
Sitagliptin phosphate monohydrate,
sitagliptin monophosphate monohydrate,
ACN-037449,
CID6451150,
CS-O-02325,
C16-H15-F6-N5-O.H3-O4-P,
C496398,
654671-77-9,
4-oxo-4-(3-(trifluoromethyl)-5,6-dihydro(1,2,4)triazolo(4,3-a)pyrazin-7(8H)-yl)-1-(2,4,5-trifluorophenyl)butan-2-amine,
790712-60-6,